Structural heart disease articles

Intervención tricuspídea heterotópica: Resultados de TricValve a un año

High Gradients After Valve-in-Valve

High Gradients After Valve-in-Valve

One of the limitations of aortic bioprostheses is their durability. When these devices fail, percutaneous valve implantation is a valid strategy. However, it has been shown that there may be high gradients involved. This gradient increase has been associated with worse outcomes and higher mortality rates, as observed in the PARTNER 2 study at 12 months.

Estenosis aórtica pura vs mixta en TAVI: beneficios y evolución

Low-Flow Aortic Stenosis: What is the Value of Valve Calcification in its Interpretation?

Delays in the treatment of symptomatic aortic stenosis (AS) reduce prognosis, especially in elderly patients. Accurate assessment of AS severity is crucial to avoid overtreatment and its associated risks. A transthoracic echocardiogram (TTE) is the initial evaluation in the diagnostic algorithm, and severity values are well established. However, some patients may obtain discordant data due

Debemos tener en cuenta a la isquemia crítica de MM II en el TAVI

TAVR vs SAVR in Los Risk Patients: 10-Year Outcomes of the NOTION Trial

Transcatheter aortic valve replacement (TAVR) has revolutionized the treatment of patients with severe aortic stenosis (AS). Randomized studies have shown the benefits of TAVR in patients at prohibitive surgical risk, as well as high and intermediate risk.  The NOTION trial (Nordic Aortic Valve Intervention Trial) randomized patients with low risk severe AS to TAVR and

TAVI: Balón expandible o autoexpandible ¿Cuál es la respuesta?

Third Generation Balloon-Expandable and Self-Expanding Valves: TAVR Meta- Analysis

TAVR’s significant advance has driven the development of valve technology, which is currently in its third generation.  Even though outcomes have improved, randomized studies are yet to compared balloon-expandable (BEV) vs self-expanding (SEV) valves in randomized studies, and we only have information from different analysis with contradicting conclusions.  This was a meta-analysis of 16 studies

EuroPCR 2024 | Self-Expanding Valves (ACURATE Neo2) vs. Balloon-Expandable Valves (Sapien 3 Ultra): 1-Year Follow-up Results

Comparing different transcatheter heart valves (THVs) is necessary to obtain relevant information that facilitates the selection of the appropriate valve for each patient. A previous study compared early outcomes between the self-expanding ACURATE Neo2 valve and the balloon-expandable Sapien 3 Ultra valve. However, there are no comparative data on these two valves in the medium

EuroPCR 2024 | NOTION-2: TAVI vs SAVR, Randomized Study on Low-Risk Young Patients with Severe Tricuspid Disease or Bicuspid Stenosis

Many of the studies comparing TAVR against SAVR in low risk patients included patients between 70-75 years, excluding those with tricuspid valves.  This study included low surgical risk patients with severe aortic stenosis and symptoms, 75 years or younger. Participants were randomized 1:1 to receiving TAVR or SAVR, stratified according to sex, need for new

EuroPCR 2024 | OBSERVANT II: TAVR in the “Real World”

This study analyzed 2,493 “real world” patients, 1,352 receiving the Evolut R/Pro, 675 the SAPIEN, 3,270 the Acurate Neo and 192 the Portico. Primary end point was all cause mortality and major adverse cardiovascular events (MACE) at 5 years.   Populations were similar, with EuroSCORE 4.9%, and there were no significant differences in comorbidities or echocardiographic

EuroPCR 2024 | SOLVE-TAVI: Self Expanding or Balloon Expandable Valves?

This was a randomized study with 447 patients carried out to compare the 5-year evolution of TAVR using Evolut R and SAPIEN 3, as well as general anesthesia vs. conscious sedation.  Randomization was in two stages: first valve selection and later the anesthesia technique, that is, conscious sedation vs general anesthesia. The populations were similar.

¿Cómo objetivar la fragilidad en pacientes con estenosis aórtica?

Aortic Stenosis Progression Evolution

Aortic stenosis is an increasingly common valvulopathy because people are living longer now. A present, the main treatment consists of surgical (SAVR) or transcatheter aortic valve replacement. (TAVR). One of the main challenges of this disease is its progression. The European guidelines recommend Doppler echocardiograms every 2 to 3 years for mild cases, mildly calcified,

angulación aórtica post TAVR

Quality of Life in Medium-Risk Patients Treated with TAVR vs SAVR

Transcatheter aortic valve replacement (TAVR) and surgical aortic valve replacement (SAVR) have demonstrated similar outcomes in symptomatic aortic stenosis patients (at high or intermediate risk) in terms of 5-year survival. When evaluating the quality of life (QoL) of these two treatment strategies in patients with high surgical risk, there were no significant differences at 5

El cierre de orejuela es seguro con los nuevos dispositivos

Evolution of Leak in Left Atrial Appendage Closure

Atrial fibrillation is common in elderly people and is associated with a higher risk of ischemic stroke. Left atrial appendage occlusion (LAAO) is a valid strategy, especially in patients at high risk of bleeding. The presence of peridevice leak (PDL) has been linked to stroke, although some analyses, such as the PROTEC-AF Study, suggest that